Intuitive Surgical
ISRGQ4 2024(ISRG Q3 FY2024)Estimated2.5% AI
AI Revenue %
2.5%
AI Fair Value
$2.2B
AI Revenue (Q)
$129.9M
Total Revenue (Q)
$5.2B
Source: SEC EDGAR 10-Q Filing
View 10-Q on SEC.govAnalysis
Q3 FY2024 total revenue $2,038.1M (Product $1,709.2M, Service $328.9M). 9M 2024 = $5,938.6M. No AI revenue disclosed. Single segment. AI risk factor present but no AI revenue quantification. ISRG's R&D spend of $286.0M (14.0% of revenue) likely includes significant AI/ML investment, but this represents cost, not revenue. The 'digital portfolio' and da Vinci 5 AI features continue to be bundled. Conservative 2.5% estimate.
Analyzed by claude-opus-4-6
Quoted Figures
Total revenue $2,038.1M (Product $1,709.2M, Service $328.9M)
10-Q 2024-09-30, Income Statement
Research and development $286.0M
10-Q 2024-09-30, Income Statement
AI Products Identified (Ring 1)
da Vinci 5 AI-enhanced visionMy Intuitive case analyticsdigital insights portfolio
AI-Enabled Items (Ring 2 — Not Counted)
These items use AI but are not counted in the AI revenue estimate because they primarily serve non-AI functions.
Instruments & Accessoriesda Vinci Xi/X systemsIon system hardware
Confidence Tier
EstimatedNo direct AI revenue disclosure — estimated from product mix